By mining the FAERS database, we comprehensively and systematically analyzed the relationship between GLP-1RA and tumors and did not find abnormally elevated GLP-1RA associated with overall tumor cases at the SOC level and most types of tumor cases at the HLGT/HLT levels
Injectable GLP-1 medications currently have a stronger and more established evidence base for weight loss, but oral options are showing meaningful results in clinical trials: In the head-to-head SURMOUNT-5 trial, researchers reported injectable tirzepatide had a mean weight reduction of about 20.2% at 72 weeks, compared with roughly 13.7% for injectable semaglutide
Its natural, gentle, and actually helps things move without causing chaos
Supplementary Figure 3 (A) Cumulative data showing relative concentrations of increased and decreased metabolites in the LC vs R group
A 20 mg vial reconstituted with bacteriostatic water yields about 10.0 mg/mL
GLP-1induced autophagy may contribute to neuroprotection, helping to prevent or slow age-related cognitive decline